Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Teva Pharmaceutical Industries ADR (NY: TEVA ) 17.66 +0.20 (+1.15%) Streaming Delayed Price Updated: 2:39 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,746,072 Open 17.55 Bid (Size) 17.65 (16) Ask (Size) 17.66 (12) Prev. Close 17.46 Today's Range 17.34 - 17.70 52wk Range 8.055 - 19.08 Shares Outstanding 1,110,352,397 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END Via FinancialNewsMedia Exposures Product Safety As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 From FN Media Group LLC Via GlobeNewswire Performance YTD +65.51% +65.51% 1 Month -5.05% -5.05% 3 Month +8.68% +8.68% 6 Month +22.38% +22.38% 1 Year +72.80% +72.80% More News Read More If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,400 Today September 16, 2024 Via Benzinga Key Takeaways From Teva Pharmaceutical Indus Analyst Ratings September 03, 2024 Via Benzinga $1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today August 21, 2024 Via Benzinga Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia September 23, 2024 From Teva Pharmaceutical Industries Ltd Via GlobeNewswire Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia September 21, 2024 From Teva Pharmaceutical Industries Ltd Via GlobeNewswire New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY® (risperidone) Extended-Release Injectable Suspension from Perseris® (RBP-7000) September 21, 2024 From Teva Pharmaceutical Industries Ltd Via GlobeNewswire Teva to Present at the Bank of America 2024 Global Healthcare Conference September 11, 2024 From Teva Pharmaceutical Industries Ltd Via GlobeNewswire UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars September 11, 2024 Via Benzinga Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies September 10, 2024 Via Benzinga JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability September 06, 2024 Via Benzinga Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production September 06, 2024 Via Benzinga Organon Stock Sees Relative Strength Rating Rise To 91 August 27, 2024 Via Investor's Business Daily Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference August 26, 2024 From Teva Pharmaceutical Industries Ltd Via GlobeNewswire Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets August 23, 2024 Via Benzinga Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold August 20, 2024 Via Investor's Business Daily $100 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth This Much Today August 13, 2024 Via Benzinga The 7 Best Under $20 Stocks to Buy in August 2024 August 07, 2024 Via InvestorPlace Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment August 06, 2024 Via PressReach Exposures Product Safety What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. August 02, 2024 Via InvestorPlace Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday? July 31, 2024 Via Benzinga Topics Economy Exposures Interest Rates Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday July 31, 2024 Via Benzinga Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript July 31, 2024 Via The Motley Fool Topics Earnings Exposures Financial Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales July 31, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
